Board Meeting Details

The Board of Directors meeting was held on Tuesday, May 26, 2026, commencing at 05:15 PM and ending at 06:00 PM.

Key Decisions Approved

1. Standalone Audited Financial Results: Approved the standalone audited financial results for the quarter and year ended March 31, 2026.

2. Internal Auditor Reappointment: Reappointed Mr. P Vishnu Adithan, Chartered Accountant, as Internal Auditor of the Company for the financial year 2026-27.

Financial Results Summary (Standalone)

Profit & Loss Statement (₹ in lakhs)

For Year Ended March 31, 2026:

  • Total Income: ₹5,489.03
  • Total Expenses: ₹5,493.98
  • Profit/(Loss) before exceptional items and tax: (₹4.95)
  • Exceptional Items (profit/loss on sale of PPE): (₹37.51)
  • Profit/(Loss) before tax: (₹42.46)
  • Tax Expense: ₹16.39
  • Current Tax: ₹5.41
  • Deferred Tax: ₹10.98
  • Net Profit/(Loss) for the period: (₹26.07)
  • Other Comprehensive Income: ₹13.73
  • Total Comprehensive Income: (₹12.34)

For Quarter Ended March 31, 2026:

  • Net Profit/(Loss) for the quarter: (₹31.95)

Balance Sheet Position (as at March 31, 2026)

  • Total Assets: ₹8,259.74 lakhs
  • Non-current Assets: ₹7,122.33 lakhs
  • Current Assets: ₹1,137.41 lakhs
  • Equity and Liabilities:
  • Equity Share Capital: ₹2,079.63 lakhs
  • Other Equity: ₹3,934.13 lakhs
  • Total Equity: ₹6,013.76 lakhs
  • Non-current Liabilities: ₹1,311.65 lakhs
  • Current Liabilities: ₹934.33 lakhs

Cash Flow Statement (Year Ended March 31, 2026)

  • Net cash from operating activities: ₹301.70 lakhs
  • Net cash used in investing activities: (₹1,236.67) lakhs
  • Net cash from financing activities: ₹902.55 lakhs
  • Net decrease in cash: (₹32.42) lakhs
  • Cash and equivalents at year-end: ₹180.83 lakhs

Additional Notes

1. Exceptional Items: Represent profit/(loss) on sale of property, plant & equipment

2. Segment Information: Company operates in single segment - "Eye Care related sales and services"

3. Labour Codes: Company assessed impact of new Labour Codes notified November 21, 2025, and does not expect material incremental liability

4. Subsidiaries: Company does not have any Subsidiary/Associate/Joint Venture

5. Previous Period Figures: Figures regrouped/rearranged for comparability